G.D. SEARLE LLC
Patent Owner
Stats
- 18 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Mar 05, 2013 most recent publication
Details
- 18 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 1,009 Total Citation Count
- Apr 10, 1992 Earliest Filing
- 55 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
RE44048 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-YL]benzenesulfonamide for the treatment of inflammation or an inflammation-associated disorderNov 14, 94Mar 05, 13[A61K]
RE43802 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSep 21, 11Nov 13, 12[A61K]
RE43596 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsApr 23, 07Aug 21, 12[A61K, C07D]
RE42889 α- and β- amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsApr 23, 07Nov 01, 11[A61K, C07D]
6410524 Combination therapy of angiotensin converting enzyme inhibitor and aldosterone antagonist for reducing morbidity and mortality from cardiovascular diseaseNov 05, 99Jun 25, 02[A61K]
6060476 .alpha.- and .beta.-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsMar 02, 94May 09, 00[A61K, C07D]
5968942 .alpha.- and .beta.-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsAug 23, 94Oct 19, 99[A61K, C07D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
7829564 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsExpiredDec 07, 07Nov 09, 10[A61K]
7531538 α- and β-Amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsExpiredMay 15, 06May 12, 09[A61K, C07C]
2008/0281,084 Formulation, Solubilization, Purification, and Refolding of Tissue Factor Pathway InhibitorAbandonedApr 05, 07Nov 13, 08[C07K]
2008/0176,842 BIS-SULFONAMIDE HYDROXYETHYLAMINO RETROVIRAL PROTEASE INHIBITORSAbandonedNov 14, 07Jul 24, 08[A61K, C07D, C07C, A61P]
2008/0118,969 BIS-AMINO ACID HYDROXYETHYLAMINO SULFONAMIDE RETROVIRAL PROTEASE INHIBITORSAbandonedJan 29, 08May 22, 08[C12N]
7339078 Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitorsExpiredAug 10, 06Mar 04, 08[C07C]
7320983 .alpha.- and .beta.-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsExpiredSep 25, 06Jan 22, 08[A61K]
7297793 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitorsExpiredFeb 08, 06Nov 20, 07[C07D]
7226757 Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitorExpiredJan 24, 06Jun 05, 07[C12P]
2007/0060,746 PROCESSES FOR PREPARATION OF 9,11 EPOXY STEROIDS AND INTERMEDIATES USEFUL THEREINAbandonedJul 21, 06Mar 15, 07[C07J]
2007/0015,818 Cyclic sulfone containing retroviral protease inhibitorsAbandonedJul 05, 06Jan 18, 07[A61K, C07D]
2006/0189,611 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitorsAbandonedJan 24, 06Aug 24, 06[A61K, C07D]
7022672 Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitorExpiredNov 30, 01Apr 04, 06[A61K]
7012094 Substituted furans and furanones for the treatment of inflammationExpiredApr 19, 95Mar 14, 06[A61K]
6890958 Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indicationsExpiredSep 18, 02May 10, 05[A61K, A01N]
2004/0176,438 Novel mono- and di-fluorinated beozothiepine copmunds as inhibitors of apical sodium co-dependent bile acid transport (ASBT) and taurocholate uptakeAbandonedDec 23, 03Sep 09, 04[A61K, C07D]
2004/0110,761 Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disordersAbandonedJul 03, 03Jun 10, 04[A61K]
6740663 Mono- and di-fluorinated benzothiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (ASBT) and taurocholate uptakeExpiredNov 04, 02May 25, 04[A61K, C07D]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.